Ignite Creation Date:
2025-12-25 @ 3:20 AM
Ignite Modification Date:
2026-02-26 @ 12:20 AM
Study NCT ID:
NCT03317405
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-28
First Post:
2017-10-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Ductal Carcinoma In Situ | View |
| None | Breast Lobular Carcinoma In Situ | View |
| None | Stage 0 Breast Cancer AJCC v6 and v7 | View |
| None | Stage I Breast Cancer AJCC v7 | View |
| None | Stage IA Breast Cancer AJCC v7 | View |
| None | Stage IB Breast Cancer AJCC v7 | View |
| None | Stage II Breast Cancer AJCC v6 and v7 | View |
| None | Stage IIA Breast Cancer AJCC v6 and v7 | View |
| None | Stage IIB Breast Cancer AJCC v6 and v7 | View |
| None | Stage III Breast Cancer AJCC v7 | View |
| None | Stage IIIA Breast Cancer AJCC v7 | View |
| None | Stage IIIB Breast Cancer AJCC v7 | View |
| None | Stage IIIC Breast Cancer AJCC v7 | View |
Keywords: